Virological rather than host factors are associated with transaminase levels among HIV/HCV-coinfected patients

Journal of the International Association of Physicians in AIDS Care

Volumn 9, Issue 1, 2010, Pages 15-19

  Shores, Nathan J ^a   Maida, Ivana ^b   Perez Saleme, Leticia ^c   Núñez, Marina ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SASSARI   (Italy)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

African American; Alanine aminotransferase (ALT); HCV; HIV

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; SEX DIFFERENCE; VIROLOGY; VIRUS LOAD;

ADULT; AFRICAN AMERICANS; ALANINE TRANSAMINASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; ITALY; MALE; MULTIVARIATE ANALYSIS; NORTH CAROLINA; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 77953674916     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109709356356     Document Type: Article

References (30)

1. Di Martino V, Rufat P, Boyer N, et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology. 2001;34(6):1193-1199.
2. Sulkowski MS, Mehta SH, Torbenson MS, et al. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS. 2007;21(16):2209-2216.
3. Yeo AET, Ghany M, Conry-Cantilena C, et al. Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers. J Viral Hepatitis. 2001;8(4):256-263.
4. Crosse K, Umeadi OG, Anania FA, et al. Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. Clin Gastroenterol Hepatol. 2004;2(6):463-468.
5. Shiffman ML, Mihas AA, Millwala F, et al. Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3. Am J Gastroenterol. 2007;102(4):761-766.
6. Sterling RK, Stravitz RT, Luketic VA, et al. A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans. Clin Gastroenterol Hepatol. 2004;2(6):469-473.
7. Wiley TE, Brown J, Chan J. Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol. 2002;97(3):700-706.
8. Sulkowski MS, Mehta SH, Torbenson M, et al. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C. AIDS. 2005;19(6):585-592.
9. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004; 39(4):1147-1171.
10. Gordon SC, Fang JWS, Silverman AL, McHutchison JG, Albrecht JK. The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C. Hepatology. 2000;32(2):400-404.
11. Zechini B, Pasquazzi C, Aceti A. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression. Eur J Gastroenterol Hepatol. 2004;16(9):891-896.
12. Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol. 2007;13(41):5481-5485.
13. Jamal MM, Son A, Quinn PG, Wheeler DE, Arora S, Johonston D. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwest United States. Hepatology. 1999;30(5):1307-1311.
14. Hu KQ, Yang H, Lin YC, Lindsay KL, Redeker AG. Clinical profiles of chronic hepatitis C in a major county medical center outpatient setting in United States. Int J Med Sci. 2004;1:92-100.
15. Mathurin P, Moussalli J, Cadranel J-F, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology. 1998;27(3):868-872.
16. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J M Ed. 1999;340(16):1228- 1233.
17. Shiffman ML, Diago M, Tran A, et al. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol. 2006;4(5):645-652.
18. Puoti C, Magrini A, Stati T, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology. 1997;26(6):1393-1398.
19. Maida I, Babudieri S, Selva C, et al. Liver enzyme elevation in hepatitis C virus (HCV) -HIV-coinfected patients prior to and after initiating HAART: role of HCV genotypes. AIDS Res Hum Retroviruses. 2006;22(2):139-143.
20. Sanchez-Conde M, Berenguer J, Miralles P, et al. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Clin Infect Dis. 2006;43(5):640-644.
21. Hagiwara H, Hayashi N, Mita E, et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology. 1993;17(4):545-550.
22. Gretch D, Corey L, Wilson J, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer correlates with advanced stage of disease. J Infect Dis. 1994;169(6):1219-1225.
23. Coelho-Little E, Jeffer LJ, Bartholomew M, Reddy HR, Schiff ER, Daily PJ. Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C. J Hepatol. 1995;22(4):248-249.
24. Adinolfi LE, Utili R, Andreana A, et al. Serum HCV-RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig Dis Sci. 2001;46 (8) : 1677-1683.
25. Agha S, Al-Gendy M, El-Ficky A, El-emshaty W. Correlation of serum hepatitic C virus RNA titre with aminotransferases and liver histopathological findings in HCV-seropositive cases with end-stage chronic liver disease. Microbes Infection. 1999;1 (13) : 1091-1094.
26. Martinot-Peignoux M, Marcellin P, Gournay J, et al. Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors. J Hepatol. 1994;20(5):676-678.
27. Gordon SC, Kodali VP, Silverman AL, et al. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol. 1994;89(9):1548-1561.
28. McCormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH. Evaluation of liver histology, ALT elevation, and HCV-RNA titer in patients with chronic hepatitis C. Am J Gastroenterol. 1996;91(8):1516-1522.
29. Fonquernie L, Serfaty L, Charrois A, et al. Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients. HIV M Ed. 2004; 5(5):385-390.
30. Uberti-Foppa C, De Bona A, Galli L, et al. Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels. J Acquir Immune Defic Syndr. 2006;41(1):63-67.